Figure 3From: The therapeutic efficacy of I131-PSCA-mAb in orthotopic mouse models of prostate cancerThe invasion abilities of PC-3 and LNCaP cells treated with I131-PSCA-mAb, I131-IgG or PSCA-mAb (** P < 0.01, compared with the cells treated with normal saline).Back to article page